Published

The psychedelic renaissance: psilocybin, a breakthrough for treatment resistant depression?

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Exploration of neuroscience
Date: 2025-08-07
Source: OpenAlex
DOI: 10.37349/en.2025.1006105
PubMed: Unavailable

Authors

Trevor R. Norman

Watch author

Derived topics and classifications

psilocybin Depression Headache / Migraine Emotional Processing Treatment-Resistant Depression Adverse Events Other

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

The psychedelic renaissance: psilocybin, a breakthrough for treatment resistant depression?2025-08-07

Related papers

Psilocybin-Assisted Therapy in Psychiatry: A Narrative Clinical Review of Mechanisms, Therapeutic Applications, and Emerging Evidence (2025-2026)Journal of Clinical Medicine · 2026-08-12 Psychedelic Therapy for DepressionUnknown journal · 2026-08-11 Psilocybin-assisted therapy for treatment-resistant major depressive disorder in a public healthcare setting: a randomized controlled trial.Nature medicine · 2026-08-06 Evaluating psilocybin for the management of depression: a literature reviewBritish Journal of Mental Health Nursing · 2026-08-02 Retreat from racism: A psychedelic group experience for racial stress and traumaPsychedelics · 2026-07-30 From trial to clinic: psilocybin's efficacy in routine treatment-resistant depression.The Lancet regional health. Europe · 2026-08-01 Ayahuasca and Salvia divinorum as contrasting modes of consciousness reorganization: Implications for psychedelic-assisted psychotherapyJournal of Psychedelic Studies · 2026-08-13 An Open-Label Trial Protocol to Test Menstrual Cycle Effects and Tolerance to Low-Dose Psilocybin in Healthy Menstruating Persons.Pharmacology · 2026-08-10